A nonsteroidal anti-inflammatory drug (nsaid) with antiplatelet properties.
An antiplatelet agent that inhibits platelet aggregation.
Reducing the risk of stroke and other thromboembolic events in patients with a history of stroke, transient ischemic attack (TIA), or peripheral artery disease.
Reducing the risk of recurrent stroke after a previous stroke.
Aspirin inhibits the production of thromboxane A2, a potent platelet aggregator. Dipyridamole inhibits adenosine uptake and phosphodiesterase, leading to increased levels of cyclic adenosine monophosphate (cAMP) within platelets, further suppressing aggregation. The combination provides a synergistic antiplatelet effect.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children.
Dosage should be determined by a physician based on individual patient needs and risk factors.
Typically administered orally, as directed by a healthcare provider.
Headache
Dizziness
Rash
Allergic reactions (rare but serious)
Bleeding from other sites (rare)
Alcohol may increase the risk of gastrointestinal bleeding; limit alcohol intake.
May cause dizziness or drowsiness; avoid driving or operating machinery if affected.
Use should be carefully considered and only under the strict supervision of a physician; risks and benefits should be weighed carefully. Consult your physician before taking this medication if you are pregnant or breastfeeding.
Not recommended for use in children unless specifically prescribed by a physician.
Caution is advised in patients with impaired kidney function; dosage adjustment may be necessary.
Caution is advised in patients with impaired liver function; dosage adjustment may be necessary.
Please consult your physician or pharmacist for specific references and detailed information.
